Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02883660 · ClinicalTrials.gov registry record
Genecept Assay and Adverse Effects of Antidepressants
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 74
- Enrollment target
NCT02883660: Completed study, sponsored by Thomas Jefferson University.
NCT02883660 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02883660 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients who have been prescribed antidepressant medications and have experienced significant adverse effects are more likely to be poor metabolizers on the CYP450 (CYP2B6, CYP2D6, CYP2C19, CYP3A4/5+) drug metabolizing enzymes and/or homozygous for the short allele of the serotonin transporter (SLC6A4) compared to patients who took an antidepressant medication and did not experience significant adverse effects but also had minimal or no response to the medication. The target medications being studied include escitalopram, citalopram, paroxetine, fluvoxamine, venlafaxine, duloxetine, bupropion, vortioxetine, vilazodone, and levomilnacipran only.
Primary Outcome
Our primary aim is to test the hypothesis that a statistically significantly higher proportion of Cases than Controls will be poor metabolizers on CYP450 isoenzymes (CYP2B6, CYP2D6, CYP2C19, CYP3A4/5+).
Interventions
- GENETIC Genocept Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2013-02 |
| Est. Completion | 2018-02-01 |
What the finished NCT02883660 record still lists
NCT02883660 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Genocept Assay is the first listed.
NCT02883660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02883660 about?
NCT02883660 is a clinical study titled "Genecept Assay and Adverse Effects of Antidepressants". The purpose of this study is to determine whether patients who have been prescribed antidepressant medications and have experienced significant adverse effects are more likely to be poor metabolizers on the CYP450 (CYP2B6, CYP2D6, CYP2C19, CYP3A4/5+) drug metabolizing enzymes and/or homozygous for t...
What is the current status of trial NCT02883660?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2013-02. Estimated completion is 2018-02-01.
What interventions are being tested in trial NCT02883660?
The interventions under investigation include: Genocept Assay (GENETIC).
Who is sponsoring clinical trial NCT02883660?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia